Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California
blank

 

Recent News and Articles on the Keywords: ameliorate diseases + compounds may + may  Related to the article below (Last Update: 5/13/2008)

Global Warming Report to March 2008 NC
Communist Party USA, NY - Apr 17, 2008
This directly threatens human life as well as crucial agricultural systems, and these glaciers may disappear as soon as the middle of this century. ...
Source: Google News

Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC … -
… , C Mallari, M Rosser, HP Ng, K May, S Monahan, JG … - Journal of Biological Chemistry, 2000 - ASBMB
... antibody was also able to ameliorate the severity ... The fact that these compounds are
quaternary ammonium ... Multiple sclerosis is an autoimmune disease mediated by ...

Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine … -
… , HP Ng, M Liang, W Zheng, K May, JG Bauman, S … - Journal of Biological Chemistry, 1998 - ASBMB
... of seven transmembrane domain receptors indicated that compound 1 is ... 1 antibody was
also able to ameliorate the severity of ongoing clinical disease. ...

Neuroprotective agents for clinical trials in Parkinson's disease A systematic assessment -
BM Ravina, SC Fagan, RG Hart, CA Hovinga, DD … - Neurology, 2003 - AAN Enterprises
... for PD only temporarily ameliorate symptoms and do ... This ubiquitously available compound
may act through adenosine ... caffeine consumption after disease onset, and ...

Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor -
M Liang, M Rosser, HP Ng, K May, JG Bauman, I … - European Journal of Pharmacology, 2000 - Elsevier
... with MIP-1a antibody was also able to ameliorate the severity ... may prove to be useful
in treatment of these diseases. ... properties of one of these compounds, 2-2 ...

[PDF] Monoamine oxidase-B inhibitors in the treatment of Alzheimer?s disease -
T Thomas - Neurobiol Aging, 2000 - utdallas.edu
... disease (AD), satisfactory approaches to ameliorate the symptoms ... is focused on delaying
the disease, as delaying ... clinical trials are several compounds that may ...
-

Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke -
CJ Vaughan, N Delanty - Stroke, 1999 - Am Heart Assoc
... thromboemboli arising from atheromatous disease outside the ... suggest that statins
can ameliorate ischemic damage ... demonstrated that these compounds may be able ...

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial … -
SE Maynard, JY Min, J Merchan, KH Lim, J Li, S … - Journal of Clinical Investigation, 2003 - pubmedcentral.nih.gov
... PlGF signaling inhibitors in other diseases, such as ... in preeclampsia, antagonizing
its effects may ameliorate symptoms. ... using small-molecule compounds aimed at ...

The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics -
J Hardy, DJ Selkoe - Science, 2002 - sciencemag.org
... including the use of compounds with antioxidant ... inhibitors and drugs that ameliorate
behavioral disturbances. ... of the earliest features of this disease. ...

Complementary and alternative medicine in chronic liver disease -
L Seeff? - Hepatology, 2001 - doi.wiley.com
... activities, that may help to ameliorate the disease. ... helpful for treat- ing liver
disease, as well ... describe multiple biologically active compounds, including 4 ...

Antioxidant Therapy in Neurologic Disease -
N Delanty, MA Dichter - Archives of Neurology, 2000 - Am Med Assoc
... potential to prevent, delay, or ameliorate many neurologic ... and need to be tailored
to individual diseases. ... role of various antioxidant compounds in neurologic ...

Source: Google Scholar

Broccoli compound may ameliorate skin disease

Last Updated: 2007-12-05 10:46:43 -0400 (Reuters Health)

By Megan Rauscher

NEW YORK (Reuters Health) - The natural compound sulforaphane, which is abundant in broccoli and other cruciferous vegetables, may have a role in the treatment of epidermolysis bullosa simplex, according to research presented during the annual meeting of the American Society for Cell Biology in Washington, DC.

Epidermolysis bullosa simplex is a genetic condition that causes the skin to become fragile and blister easily from minor injuries or friction, such as rubbing or scratching. The signs and symptoms of the condition vary widely -- blistering may primarily affect the hands and feet and heals, while severe cases involve widespread blistering that can lead to infection, dehydration and may be life-threatening in infants.

In a telephone interview with Reuters Health, Dr. Pierre A. Coulombe, of Johns Hopkins University School of Medicine, Baltimore, noted that most cases of epidermolysis bullosa simplex are due to mutations in the genes encoding the proteins keratin 5 (K5) or keratin 14 (K14), proteins that normally form skins cells.

The idea of using topical sulforaphane to treat epidermolysis bullosa simplex, the researcher explained, takes advantage of a functional redundancy within the keratin gene family.

"We show that we can achieve a significant degree of amelioration of skin blistering in a mouse model of epidermolysis bullosa simplex by treating with sulforaphane that is able to turn on two keratin genes, whose sequence and properties are very related to one of the two keratin genes that is defective in epidermolysis bullosa simplex," Coulombe told Reuters Health.

Sulforaphane treatment results in the production of skin cells that relieve the blistering caused by a K14 deficiency in the mouse mode of epidermolysis bullosa simplex.

Sulforaphane and similar drugs "represent promising options for the prevention of skin blistering associated with K14 mutations in epidermolysis bullosa simplex," the investigators write.

Currently available treatments for epidermolysis bullosa simplex only relieve the symptoms, rather than provide a cure, and they also yield limited success. Coulombe hopes that one day sulforaphane may be a major treatment or component of treatment for patients with epidermolysis bullosa simplex.

The investigators are in the very early stages of trying to translate this into patients. "We already have some indications that when applied to human skin, sulforaphane will induce the right kind of keratin genes," Coulombe noted.

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.